Journey Medical Corporation
DERM · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $17,631 | $15,009 | $13,139 | $13,620 |
| % Growth | 17.5% | 14.2% | -3.5% | – |
| Cost of Goods Sold | $5,755 | $6,003 | $4,790 | $2,237 |
| Gross Profit | $11,876 | $9,006 | $8,349 | $11,383 |
| % Margin | 67.4% | 60% | 63.5% | 83.6% |
| R&D Expenses | $287 | $0 | $39 | $218 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $0 | $11,882 | $10,569 | $10,060 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $13,118 | $0 | $1,065 | -$1,129 |
| Operating Expenses | $13,405 | $11,882 | $11,673 | $9,149 |
| Operating Income | -$1,529 | -$2,876 | -$3,324 | $2,234 |
| % Margin | -8.7% | -19.2% | -25.3% | 16.4% |
| Other Income/Exp. Net | -$786 | -$860 | -$749 | -$652 |
| Pre-Tax Income | -$2,315 | -$3,736 | -$4,073 | $1,582 |
| Tax Expense | $0 | $60 | $0 | $61 |
| Net Income | -$2,315 | -$3,796 | -$4,073 | $1,521 |
| % Margin | -13.1% | -25.3% | -31% | 11.2% |
| EPS | -0.09 | -0.16 | -0.18 | 0.069 |
| % Growth | 43.8% | 11.1% | -362% | – |
| EPS Diluted | -0.09 | -0.16 | -0.18 | 0.069 |
| Weighted Avg Shares Out | 24,959 | 23,291 | 22,611 | 22,154 |
| Weighted Avg Shares Out Dil | 24,959 | 23,291 | 22,611 | 22,154 |
| Supplemental Information | – | – | – | – |
| Interest Income | $154 | $138 | $149 | $191 |
| Interest Expense | $937 | $937 | $891 | $831 |
| Depreciation & Amortization | $1,064 | $1,086 | $1,086 | $1,003 |
| EBITDA | -$314 | -$1,713 | -$2,096 | $3,416 |
| % Margin | -1.8% | -11.4% | -16% | 25.1% |